Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Treasury Shares: 2015-2024

Historic Treasury Shares for ImmunityBio (IBRX) over the last 10 years, with Dec 2024 value amounting to $163,800.

  • ImmunityBio's Treasury Shares changed negligibly% to $163,800 in Q3 2025 from the same period last year, while for Sep 2025 it was $163,800, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $163,800 for FY2024, which is negligibly% changed negligibly from last year.
  • ImmunityBio's Treasury Shares amounted to $163,800 in FY2024, which was down 0.00% from $163,800 recorded in FY2023.
  • ImmunityBio's Treasury Shares' 5-year high stood at $163,800 during FY2020, with a 5-year trough of $163,800 in FY2020.
  • Moreover, its 3-year median value for Treasury Shares was $163,800 (2024), whereas its average is $163,800.
  • Data for ImmunityBio's Treasury Shares shows a maximum YoY tumbled of 75.85% (in 2020) over the last 5 years.
  • Over the past 5 years, ImmunityBio's Treasury Shares (Yearly) stood at $163,800 in 2020, then remained steady at $163,800 in 2021, then remained steady at $163,800 in 2022, then remained steady at $163,800 in 2023, then remained steady at $163,800 in 2024.